KYTHERA Biopharmaceuticals Announces 2013 Operating Results
March 17, 2014 16:05 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its quarter and year ended December 31, 2013, and provided...
KYTHERA Acquires Rights to ATX-101 Outside of the U.S. and Canada From Bayer Consumer Care
March 10, 2014 16:05 ET
|
KYTHERA Biopharmaceuticals, Inc.
KYTHERA Now Holds Global Rights to ATX-101
KYTHERA to Host Conference Call Today at 4:30 ET
CALABASAS, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH)...
KYTHERA Biopharmaceuticals to Release 2013 Operating Results
March 10, 2014 09:25 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its fourth quarter and full year 2013 operating results and will...
KYTHERA Biopharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference
February 28, 2014 16:33 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Feb. 28, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Cowen...
KYTHERA Biopharmaceuticals to Present at 32nd Annual J.P. Morgan Healthcare Conference
January 06, 2014 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the 32nd...
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index
December 19, 2013 17:50 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Dec. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:NBI),...
KYTHERA Biopharmaceuticals Announces Third Quarter 2013 Operating Results
November 14, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, Nov. 14, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2013, and provided an update on recent...
KYTHERA Biopharmaceuticals to Release Third Quarter 2013 Operating Results
November 01, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Nov. 1, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its third quarter 2013 operating results and will host an investor...
KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
October 08, 2013 19:44 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Oct. 8, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the pricing of an underwritten public offering of 2,622,950 shares of its common...
KYTHERA Biopharmaceuticals Announces Proposed Public Offering of Common Stock
October 07, 2013 16:02 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Oct. 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has commenced an underwritten public offering of shares of its common stock to...